Compounds and methods for diagnosing prostate cancer are provided. The
inventive compounds include polypeptides containing at least a portion of a prostate
tumor protein. The inventive polypeptides may be used to generate antibodies useful
for the diagnosis and monitoring of prostate cancer. Nucleic acid sequences for
preparing probes, primers, and polypeptides are also provided.
